ZA845820B - Aminopyrimidinone derivatives as histamine h2-antagonists - Google Patents

Aminopyrimidinone derivatives as histamine h2-antagonists

Info

Publication number
ZA845820B
ZA845820B ZA845820A ZA845820A ZA845820B ZA 845820 B ZA845820 B ZA 845820B ZA 845820 A ZA845820 A ZA 845820A ZA 845820 A ZA845820 A ZA 845820A ZA 845820 B ZA845820 B ZA 845820B
Authority
ZA
South Africa
Prior art keywords
histamine
antagonists
hydrogen
zero
aminopyrimidinone
Prior art date
Application number
ZA845820A
Other languages
English (en)
Inventor
Thomas Henry Brown
David Tuddenham
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Publication of ZA845820B publication Critical patent/ZA845820B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
ZA845820A 1983-07-29 1984-07-27 Aminopyrimidinone derivatives as histamine h2-antagonists ZA845820B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320505A GB8320505D0 (en) 1983-07-29 1983-07-29 Chemical compounds

Publications (1)

Publication Number Publication Date
ZA845820B true ZA845820B (en) 1985-06-26

Family

ID=10546495

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA845820A ZA845820B (en) 1983-07-29 1984-07-27 Aminopyrimidinone derivatives as histamine h2-antagonists

Country Status (21)

Country Link
EP (1) EP0134096B1 (ja)
JP (1) JPS6051179A (ja)
KR (1) KR850001174A (ja)
AT (1) ATE40552T1 (ja)
AU (1) AU564650B2 (ja)
CA (1) CA1261831A (ja)
CS (1) CS244448B2 (ja)
DD (1) DD216933A5 (ja)
DE (1) DE3476541D1 (ja)
DK (1) DK368284A (ja)
ES (1) ES534620A0 (ja)
FI (1) FI842976A (ja)
GB (1) GB8320505D0 (ja)
GR (1) GR82226B (ja)
HU (1) HUT34743A (ja)
IL (1) IL72491A0 (ja)
JO (1) JO1327B1 (ja)
NO (1) NO843043L (ja)
PT (1) PT78977B (ja)
ZA (1) ZA845820B (ja)
ZW (1) ZW11584A1 (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772704A (en) * 1983-09-21 1988-09-20 Bristol-Myers Company 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
GB8421427D0 (en) * 1984-08-23 1984-09-26 Smith Kline French Lab Chemical compounds
CN1972914A (zh) 2004-03-31 2007-05-30 詹森药业有限公司 作为组胺h3受体配合体的非咪唑杂环化合物
CA2653940C (en) 2006-05-30 2015-07-14 Janssen Pharmaceutica N.V. Substituted pyridyl amide compounds as modulators of the histamine h3 receptor
CN105712977B (zh) 2007-11-20 2021-06-29 詹森药业有限公司 作为组胺h3受体调节剂的环烷基氧基吡啶化合物和杂环烷基氧基吡啶化合物
US20230349922A1 (en) 2020-08-11 2023-11-02 Université De Strasbourg H2 Blockers Targeting Liver Macrophages for the Prevention and Treatment of Liver Disease and Cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN151188B (ja) * 1978-02-13 1983-03-05 Smith Kline French Lab
ZA793443B (en) * 1978-07-26 1980-12-31 Glaxo Group Ltd Heterocyclic derivatives
US4496567A (en) * 1978-11-13 1985-01-29 Smith Kline & French Laboratories Limited Phenyl alkylaminopyrimidones
US4521418A (en) * 1979-02-21 1985-06-04 Smith Kline & French Laboratories Limited Guanidinothiazolyl derivatives
ZW21281A1 (en) * 1980-10-01 1981-11-18 Smith Kline French Lab Amine derivatives
NZ202797A (en) * 1981-12-28 1985-08-30 Lilly Co Eli Pyrimidine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
FI842976A (fi) 1985-01-30
DE3476541D1 (de) 1989-03-09
DD216933A5 (de) 1985-01-02
EP0134096A2 (en) 1985-03-13
DK368284A (da) 1985-01-30
EP0134096B1 (en) 1989-02-01
CA1261831A (en) 1989-09-26
EP0134096A3 (en) 1985-12-18
ES8600254A1 (es) 1985-09-16
JO1327B1 (en) 1986-11-30
CS581084A2 (en) 1985-08-15
NO843043L (no) 1985-01-30
IL72491A0 (en) 1984-11-30
AU564650B2 (en) 1987-08-20
PT78977B (en) 1986-06-05
ZW11584A1 (en) 1985-04-17
CS244448B2 (en) 1986-07-17
HUT34743A (en) 1985-04-28
PT78977A (en) 1984-08-01
GR82226B (ja) 1984-12-13
DK368284D0 (da) 1984-07-27
ATE40552T1 (de) 1989-02-15
GB8320505D0 (en) 1983-09-01
AU3099184A (en) 1985-01-31
FI842976A0 (fi) 1984-07-26
JPS6051179A (ja) 1985-03-22
ES534620A0 (es) 1985-09-16
KR850001174A (ko) 1985-03-16

Similar Documents

Publication Publication Date Title
DE3069408D1 (en) 5-oxo- and 5-thioxoproline derivatives, process for their production and pharmaceutical compositions containing them
EP0134096A3 (en) Aminopyrimidinone derivatives as histamine h2-antagonists
EP0180298A3 (en) Pyrimidine compounds
AU7414691A (en) New 3-aminochroman derivatives, process for preparing these and pharmaceutical compositions containing them
ZA843088B (en) Aminoimidazolinone derivatives as h2-antagonists
SE8303913D0 (sv) Heterocykliska foreningar
ES8602764A1 (es) Un procedimiento para preparar derivados de tiadiazina
EP0143630A3 (en) Chemical compounds
IE832323L (en) Dioxocyclobutenes
HUT39158A (en) Process for preparing carbacyclines and pharmaceutical compositions containing such compounds
DE3163803D1 (en) 2-methyl-5-thiazole-methylamine and carboxamide derivatives
DE3070032D1 (en) Aminoalkyl benzofuran derivatives, their production and compositions containing them
IL61233A (en) Guanidino thiazolylalkylamino(alkylthioalkylamino)nitro pyrroles,process for their preparation and pharmaceutical compositions containing them